Salus, Ljubljana, D. D. Reports Earnings Results for the Half Year Ended June 30, 2021
August 12, 2021
Share
SALUS, Ljubljana, d. D. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 217.490 million compared to EUR 191.977 million a year ago. Operating income was EUR 8.400 million compared to EUR 5.507 million a year ago. Net income was EUR 7.391 million compared to EUR 4.168 million a year ago. Basic earnings per share from continuing operations was EUR 70.82 compared to EUR 39.94 a year ago.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Company's portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.